Ulcerative Colitis Awareness

Adam S. Cheifetz, MD, director of the Center for Inflammatory Bowel Disease, medical director of Infusion Services at Beth Israel Deaconess Medical Center, and professor of medicine at Harvard Medical School, spoke with Healio about ulcerative colitis.

In these videos, Cheifetz discussed:

• Lessons learned throughout the COVID-19 pandemic, as well as its impact on the treatment and management of patients with UC;
• Ways to improve health equity for patients;
• One of the “holy grails” of UC management – personalized care – and how research in UC should be directed toward finding individual markers of response to different treatment;
• Improving the use of therapeutic drug monitoring, particularly for patients on anti-TNF therapy;
• How clinicians can engage their patients in conversation about complementary therapy; and
• Wider awareness of UC destigmatizing the disease as well as make it easier for patients to talk about abdominal pain, gas or poop with clinicians.